8BGA
Structure of Mpro in complex with FGA146
Summary for 8BGA
Entry DOI | 10.2210/pdb8bga/pdb |
Descriptor | 3C-like proteinase nsp5, 4-methoxy-~{N}-[(2~{S})-4-methyl-1-[[(2~{S})-4-nitro-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]-1~{H}-indole-2-carboxamide (3 entities in total) |
Functional Keywords | mpro, sars-cov-2, fga146, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 2 |
Total formula weight | 68626.19 |
Authors | Medrano, F.J.,Romero, A. (deposition date: 2022-10-27, release date: 2023-11-08, Last modification date: 2024-03-27) |
Primary citation | Medrano, F.J.,de la Hoz-Rodriguez, S.,Marti, S.,Arafet, K.,Schirmeister, T.,Hammerschmidt, S.J.,Muller, C.,Gonzalez-Martinez, A.,Santillana, E.,Ziebuhr, J.,Romero, A.,Zimmer, C.,Weldert, A.,Zimmermann, R.,Lodola, A.,Swiderek, K.,Moliner, V.,Gonzalez, F.V. Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. Commun Chem, 7:15-15, 2024 Cited by PubMed: 38238420DOI: 10.1038/s42004-024-01104-7 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.982 Å) |
Structure validation
Download full validation report